Skip to main content
TipRanks
Go Ultimate75% OFF

Sionna Therapeutics, Inc. (SION) Ratios

71 Followers

Sionna Therapeutics, Inc. Ratios

SION's free cash flow for Q3 2026 was $-18.72M. For the 2026 fiscal year, SION's free cash flow was increased by $0.00 and operating cash flow was $-18.72M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio20.6114.494.8810.16
Quick Ratio20.6114.494.8810.16
Cash Ratio4.993.634.796.64
Solvency Ratio-3.90-0.17-0.28-0.26
Operating Cash Flow Ratio-5.66-5.07-5.44-4.37
Short-Term Operating Cash Flow Coverage0.000.000.000.00
Net Current Asset Value$ 222.30M$ -198.47M$ -127.62M$ -73.46M
Leverage Ratios
Debt-to-Assets Ratio0.030.050.200.00
Debt-to-Equity Ratio0.03-0.06-0.090.00
Debt-to-Capital Ratio0.03-0.06-0.100.00
Long-Term Debt-to-Capital Ratio0.000.000.000.00
Financial Leverage Ratio1.06-1.13-0.45-1.25
Debt Service Coverage Ratio0.000.000.000.00
Interest Coverage Ratio0.000.000.000.00
Debt to Market Cap0.000.000.000.00
Interest Debt Per Share0.220.220.240.00
Net Debt to EBITDA0.670.460.561.33
Profitability Margins
Gross Profit Margin0.00%0.00%0.00%0.00%
EBIT Margin0.00%0.00%0.00%0.00%
EBITDA Margin0.00%0.00%0.00%0.00%
Operating Profit Margin0.00%0.00%0.00%0.00%
Pretax Profit Margin0.00%0.00%0.00%0.00%
Net Profit Margin0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin0.00%0.00%0.00%0.00%
Net Income Per EBT100.00%100.00%100.00%100.00%
EBT Per EBIT84.59%87.43%93.90%97.26%
Return on Assets (ROA)-23.09%-33.21%-90.99%-46.06%
Return on Equity (ROE)-24.53%37.68%41.14%57.55%
Return on Capital Employed (ROCE)-28.32%-40.24%-114.63%-52.29%
Return on Invested Capital (ROIC)-28.20%-40.00%-112.76%-52.29%
Return on Tangible Assets-23.09%-33.21%-90.99%-46.06%
Earnings Yield-4.58%-5.59%-4.28%-3.65%
Efficiency Ratios
Receivables Turnover0.000.000.000.00
Payables Turnover0.840.560.000.00
Inventory Turnover0.000.000.000.00
Fixed Asset Turnover0.000.000.000.00
Asset Turnover0.000.000.000.00
Working Capital Turnover Ratio0.000.000.000.00
Cash Conversion Cycle-433.83-648.040.000.00
Days of Sales Outstanding0.000.000.000.00
Days of Inventory Outstanding0.000.000.000.00
Days of Payables Outstanding433.83648.040.000.00
Operating Cycle0.000.000.000.00
Cash Flow Ratios
Operating Cash Flow Per Share-1.66-1.20-0.99-0.82
Free Cash Flow Per Share-1.67-1.20-1.02-0.86
Dividend Paid and CapEx Coverage Ratio-175.85-1955.07-39.16-19.25
Capital Expenditure Coverage Ratio-175.85-1955.07-39.16-19.25
Operating Cash Flow Coverage Ratio-7.64-5.41-4.170.00
Operating Cash Flow to Sales Ratio0.000.000.000.00
Free Cash Flow Yield-4.06%-4.79%-4.06%-3.44%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-21.88-17.86-23.34-27.41
Price-to-Sales (P/S) Ratio0.000.000.000.00
Price-to-Book (P/B) Ratio5.36-6.74-9.60-15.78
Price-to-Free Cash Flow (P/FCF) Ratio-24.66-20.89-24.61-29.07
Price-to-Operating Cash Flow Ratio-24.80-20.90-25.24-30.58
Price-to-Earnings Growth (PEG) Ratio-0.64-0.58-1.340.00
Enterprise Value Multiple-21.36-17.62-21.61-25.41
Enterprise Value1.59B1.08B1.08B1.05B
EV to EBITDA-21.36-17.62-21.61-25.41
EV to Sales0.000.000.000.00
EV to Free Cash Flow-23.91-20.36-23.99-27.63
EV to Operating Cash Flow-24.05-20.37-24.60-29.06
Tangible Book Value Per Share7.68-3.71-2.60-1.58
Shareholders’ Equity Per Share7.68-3.71-2.60-1.58
Tax and Other Ratios
Effective Tax Rate0.000.000.000.00
Revenue Per Share0.000.000.000.00
Net Income Per Share-1.88-1.40-1.07-0.91
Tax Burden1.001.001.001.00
Interest Burden1.001.000.940.97
Research & Development to Revenue0.000.000.000.00
SG&A to Revenue0.000.000.000.00
Stock-Based Compensation to Revenue0.000.000.000.00
Income Quality0.880.860.920.90

Currency in USD